The Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United States.
暂无分享,去创建一个
M. Weinstein | R. Walensky | R. Parker | K. Freedberg | P. Sax | B. Taiwo | A. Paltiel | R. Gulick | Michael P. Girouard | Robert A. Parker